Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity

The small-molecule inhibitor of p53-Mdm2 interaction, Nutlin-3, is known to be effective against cancers expressing wild-type (wt) p53. p53 mutations are rare in nasopharyngeal carcinoma (NPC), hence targeting disruption of p53-Mdm2 interaction to reactivate p53 may offer a promising therapeutic str...

Descripción completa

Detalles Bibliográficos
Autores principales: VOON, YEE-LIN, AHMAD, MUNIRAH, WONG, POOI-FONG, HUSAINI, ROSLINA, NG, WAYNE TIONG-WENG, LEONG, CHEE-ONN, LANE, DAVID PHILIP, KHOO, ALAN SOO-BENG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564086/
https://www.ncbi.nlm.nih.gov/pubmed/26252575
http://dx.doi.org/10.3892/or.2015.4177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564086/
https://www.ncbi.nlm.nih.gov/pubmed/26252575
http://dx.doi.org/10.3892/or.2015.4177

Ejemplares similares